Related Experiment Video
Updated: Jan 15, 2026

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
Published on: June 27, 2025
Screening for Pulmonary Hypertension in Connective Tissue Diseases: Literature Review and Multidisciplinary Consensus
Alper Sarı1, Duygu Temiz Karadağ2, Mustafa Erdoğan3
1Department of Rheumatology, Etlik City Hospital, Ankara, Türkiye.
Patients with connective tissue diseases (CTDs) face higher risks of pulmonary hypertension (PH). Early PH detection via screening, particularly echocardiography for systemic sclerosis (SSc) patients, may improve outcomes.
Area of Science:
- Rheumatology
- Cardiology
- Pulmonology
- Medical Screening
Background:
- Connective tissue diseases (CTDs) increase the risk of pulmonary hypertension (PH) and pulmonary arterial hypertension (PAH).
- Early detection of PH in CTD patients is linked to improved outcomes.
- Current screening methods for PH in CTDs include imaging, biomarkers, and pulmonary function tests.
Purpose of the Study:
- To develop consensus-based recommendations and a screening algorithm for PH in patients with CTDs.
- To synthesize evidence from a systematic literature review on PH screening methods in CTDs.
- To provide guidance for early PH detection in high-risk CTD populations.
Main Methods:
- A multidisciplinary consensus group (10 rheumatologists, 4 cardiologists, 3 pulmonologists) was convened.
- A systematic literature review of the PubMed database was conducted to identify relevant studies.
- Consensus was reached based on literature data and expert opinion.
Main Results:
- 33 relevant articles were identified through the literature review.
- Significant heterogeneity was noted in study definitions, cutoff values, and patient symptom status.
- An algorithm prioritizing echocardiography for PH screening in systemic sclerosis (SSc) and SSc-overlap CTD patients was developed.
Conclusions:
- Echocardiography is recommended for screening and early detection of PH in SSc patients and those with SSc overlap features.
- Limited data prevents recommendations for asymptomatic CTD patients without SSc overlap.
- Further research is needed to establish screening guidelines for broader CTD populations.
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

